These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17353638)

  • 1. [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].
    Akahane T; Chiba T; Yano H; Hashimoto Y
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):435-8. PubMed ID: 17353638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
    Murakami S; Yamamoto Y
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1147-9. PubMed ID: 17637560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].
    Suzuki M
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):69-72. PubMed ID: 17220673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of far advanced breast cancer with distant metastases which had mostly disappeared after chemoendocrine therapy].
    Nishimura H; Takasuna K; Kondo R; Hayashi K; Munakata Y; Kasuga Y
    Gan To Kagaku Ryoho; 2000 May; 27(5):753-7. PubMed ID: 10832447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
    Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A patient with metastatic breast cancer associated with retention of pleural effusion with no response to both CMF and exemestane, whose life was saved by high-dose toremifene].
    Sagara H; Okayama H; Ohtake T; Yasuda M; Watanabe K; Takenoshita S
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):255-9. PubMed ID: 15751645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes.
    Schaller G; Fuchs I; Gonsch T; Weber J; Kleine-Tebbe A; Klare P; Hindenburg HJ; Lakner V; Hinke A; Bangemann N
    J Clin Oncol; 2007 Aug; 25(22):3246-50. PubMed ID: 17577021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial.
    Yamamoto D; Iwase S; Kitamura K; Odagiri H; Yamamoto C; Nagumo Y
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):509-14. PubMed ID: 17516068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case report of advanced breast cancer responding to capecitabine and trastuzumab combination therapy].
    Yoshidome K; Imabun S; Nakahara M; Hiraoka K; Yamagami Y; Tsujimoto M; Nakao K
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1453-6. PubMed ID: 17033236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA].
    Konishi K; Hasegawa N; Kawabata M; Abeshima S; Ichimura T; Kaneko H; Nakayama T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1689-91. PubMed ID: 17940392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
    Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
    Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].
    Iida S; Furukawa K; Yokoyama T; Yanagihara K; Iwasaki R; Noguchi T; Tsuchiya S; Sugisaki Y; Naito Z; Tajiri T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1697-700. PubMed ID: 17940394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
    Campone M; Isambert N; Bourbouloux E; Roché H; Bonneterre J; Milano G; Fumoleau P
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):871-9. PubMed ID: 22045498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of severe hand-foot syndrome caused by capecitabine].
    Shimomatsuya T; Mitsudou Y; Nakamura T; Yonezawa K; Shiraishi S; Fujino M; Maruhashi K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1139-41. PubMed ID: 17637558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of metastatic breast cancer responding to weekly paclitaxel and high-dose toremifene administrated alternately].
    Murakami H; Noda S; Okamura Y; Sakakibara T; Ishikawa T; Nakamura H; Yaguchi T; Harada A
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1963-6. PubMed ID: 12465396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group.
    Masuda N; Taguchi T; Nakayama T; Shiba E; Watatani M; Kurebayashi J; Takatsuka Y; Sakamoto J; Noguchi S;
    Cancer Chemother Pharmacol; 2008 May; 61(6):989-95. PubMed ID: 17641893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.
    Lebowitz PF; Eng-Wong J; Swain SM; Berman A; Merino MJ; Chow CK; Venzon D; Zia F; Danforth D; Liu E; Zujewski J
    Clin Cancer Res; 2004 Oct; 10(20):6764-9. PubMed ID: 15501952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A paclitaxel-resistant case of recurrent breast cancer responded to combination therapy of capecitabine and trastuzumab].
    Marutaka M; Suguri T; Miyake M; Yoshimura K
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2137-9. PubMed ID: 16352945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.